Do Not Discontinue or Delay Cancer Treatment That May Impact Survival

Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression

Lung Cancer Treatment Plans Changed Due to Pandemic – 57 percent of patients receiving active treatment had at least one change in treatment plans